Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders

Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders

US Patent 11007230 · Granted May 18, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Plasma derived from human umbilical cord blood for the treatment of neurodegener2024
Plasma derived from human umbilical cord blood for the treatment of neurodegener2024
Plasma derived from human umbilical cord blood for the treatment of neurodegener2024
Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-2023
Plasma derived from human umbilical cord blood for the treatment of neurodegener2023
Plasma derived from human umbilical cord blood for the treatment of neurodegener2023
Plasma derived from human umbilical cord blood for the treatment of neurodegener2023
Method of stem cell delivery into the brain during chronic disease using blood b2020
Ischemic tissue cell therapy2019
Non-invasive method for direct delivery of therapeutics to the spinal cord in th2019
Exo-S-mecamylamine formulation and use in treatment2019
Combination therapy of stem cell mobilizing agents and stem cell transplantation2018